ATE409226T1 - Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1) - Google Patents

Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)

Info

Publication number
ATE409226T1
ATE409226T1 AT99922437T AT99922437T ATE409226T1 AT E409226 T1 ATE409226 T1 AT E409226T1 AT 99922437 T AT99922437 T AT 99922437T AT 99922437 T AT99922437 T AT 99922437T AT E409226 T1 ATE409226 T1 AT E409226T1
Authority
AT
Austria
Prior art keywords
pcta
markers
prostate cancer
polymorphoic
tumor antigen
Prior art date
Application number
AT99922437T
Other languages
English (en)
Inventor
Marta Blumenfeld
Lydie Bougueleret
Ilya Chumakov
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE409226T1 publication Critical patent/ATE409226T1/de

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biotechnology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99922437T 1998-06-05 1999-06-04 Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1) ATE409226T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8818798P 1998-06-05 1998-06-05
US10232498P 1998-09-28 1998-09-28

Publications (1)

Publication Number Publication Date
ATE409226T1 true ATE409226T1 (de) 2008-10-15

Family

ID=26778388

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922437T ATE409226T1 (de) 1998-06-05 1999-06-04 Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)

Country Status (7)

Country Link
EP (1) EP1084239B1 (de)
JP (1) JP2002517242A (de)
AT (1) ATE409226T1 (de)
AU (1) AU773006B2 (de)
CA (1) CA2328500A1 (de)
DE (1) DE69939623D1 (de)
WO (1) WO1999064590A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1121437B1 (de) 1998-10-15 2008-02-20 Novartis Vaccines and Diagnostics, Inc. Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
CA2383871A1 (en) * 1999-06-25 2001-01-04 Genset S.A. A novel bap28 gene and protein
WO2001075163A2 (en) * 2000-04-04 2001-10-11 Polygenyx, Inc. High throughput methods for haplotyping
US6844154B2 (en) 2000-04-04 2005-01-18 Polygenyx, Inc. High throughput methods for haplotyping
US20060009378A1 (en) * 2002-11-14 2006-01-12 Itshak Golan Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
EP2522743A3 (de) * 2007-02-07 2013-08-07 Decode Genetics EHF. Zum Prostatakrebsrisiko beitragende genetische Varianten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851764A (en) * 1990-10-25 1998-12-22 The Trustees Of Columbia University In The City Of New York Human prostate tumor inducing gene-1 and uses thereof
WO1998007830A2 (en) * 1996-08-22 1998-02-26 The Institute For Genomic Research COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
US5856104A (en) * 1996-10-28 1999-01-05 Affymetrix, Inc. Polymorphisms in the glucose-6 phosphate dehydrogenase locus
WO1998020165A2 (en) * 1996-11-06 1998-05-14 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
EP1084239B1 (de) 2008-09-24
DE69939623D1 (de) 2008-11-06
CA2328500A1 (en) 1999-12-16
AU773006B2 (en) 2004-05-13
JP2002517242A (ja) 2002-06-18
WO1999064590A1 (en) 1999-12-16
EP1084239A1 (de) 2001-03-21
AU3951499A (en) 1999-12-30

Similar Documents

Publication Publication Date Title
DK1071710T3 (da) Genomisk sekvens for 5-lipoxygenase-aktiveringsproteinet (FLAP), polymorfe markörer deri og fremgangsmåder til påvisning af astma
WO2004086949A3 (en) Dna markers for management of cancer
BR0209646A (pt) genes expressos em cáncer de mama como alvos de prognósticos e terapêuticos
DK3059322T3 (da) Genekspressionsmarkører for brystcancerprognose
WO2003021227A3 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
WO1997036535A3 (en) Biomarkers for detection, diagnosis and prognosis of prostate cancer
HUP0302332A2 (hu) Génkimutatási eljárás ErbB-antagonistával végzett rákterápiára adott hatékony reakció valószínûségének növelésére
Su et al. Desmoplastic and neurotropic melanoma: analysis of 33 patients with lymphatic mapping and sentinel lymph node biopsy
Swalwell et al. Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer
AU2003293141A1 (en) Methods for identifying risk of breast cancer and treatments thereof
WO2001025791A3 (en) Prostate cancer marker proteins
ATE332979T1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
NZ338068A (en) Diagnosis of early gastric cancer detecting cyclooxygenase-2 mRNA expression or Cox-2 protein overexpression
ATE409226T1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
EP1108789A3 (de) Quantifizierung der Expression der hTERT-mRNS
WO2000056924A3 (en) Genomic sequence of the purh gene and purh-related biallelic markers
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
DK1222266T3 (da) PCA3-messenger-RNA i benigne og maligne prostatavæv
WO2000058509A3 (en) Prostate cancer associated human fibronectin gene and biallelic markers
ATE329597T1 (de) Die verwendung von einer 4- pyridylmethylphtalazine enthaltenden kombination zur behandlung von tumoren
DE60135743D1 (de) Liposomale einkapselung von alphastrahlern, und deren verwendung
EP1038025A4 (de) Genetische veränderungen im zusammenhang mit krebs
WO2006069306A3 (en) A knockout mouse for the tumor suppressor gene anx7
DE60134956D1 (de) Gene differentiell experimiert in brudtkrebs
BR0012301A (pt) Inibidores de crescimento de células epiteliais

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties